Skip to main content

Cornell seeds urban farming in the Big Apple

Cornell Cooperative Extension-New York City will help to sow innovative urban agriculture projects in Big Apple schools, Manhattan borough president Gale Brewer announced at an April 30 press conference.

Inside Medicine at Weill Cornell: Peer mentorship

The second episode of the video series Inside Medicine at Weill Cornell chronicles the relationship between Drs. BJ Casey, a neuroscientist, and Conor Liston, assistant professor.

President Skorton sends end of year message

President David Skorton's final end-of-year message reflects on the challenges and accomplishments of the past year and what they mean for Cornell's future.

Inside Medicine at Weill Cornell: the dean as mentor

In the first of a series of Inside Medicine at Weill Cornell videos focusing on mentorship, explore the relationship between Dr. Sarah Bettigole and her mentor, WCMC Dean Dr. Laurie Glimcher.

Community celebrates poetry with readings – and pastry

Shawkat Toorawa led student, faculty and guest poets in sharing verse from New York City, the Near East and other cultures at a "Poetry and Pastry" Sesquicentennial event at the Johnson Museum.

Epigenome could reverse lymphoma treatment resistance

Weill Cornell Medical College researchers have found an epigenome in cancer cells that may lead to treatment for recurrences after treatment in certain lymphomas.

Weill Cornell video series spotlights culture of mentorship

Weill Cornell Medical College is launching a video series highlighting its culture of mentorship, an essential ingredient of excellent health care, research and education.

Cornell Tech hosts computer hack day for kids, seniors

More than 30 Cornell Tech students taught coding and computer literacy to middle school students and senior citizens last week on Manhattan's Roosevelt Island.

Discovery of genetic mutations may lead to lymphoma therapy

An international team of researchers has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. The findings could lead to new targeted therapies for this aggressive disease.